| Literature DB >> 27545894 |
Yoshinori Takeuchi1, Naoya Yahagi2, Yuichi Aita1, Yuki Murayama1, Yoshikazu Sawada1, Xiaoying Piao1, Naoki Toya1, Yukari Oya1, Akito Shikama1, Ayako Takarada1, Yukari Masuda1, Makiko Nishi1, Midori Kubota1, Yoshihiko Izumida1, Takashi Yamamoto3, Motohiro Sekiya3, Takashi Matsuzaka3, Yoshimi Nakagawa3, Osamu Urayama3, Yasushi Kawakami3, Yoko Iizuka4, Takanari Gotoda4, Keiji Itaka5, Kazunori Kataoka5, Ryozo Nagai4, Takashi Kadowaki4, Nobuhiro Yamada3, Yuan Lu6, Mukesh K Jain6, Hitoshi Shimano3.
Abstract
Hepatic lipogenesis is nutritionally regulated (i.e., downregulated during fasting and upregulated during the postprandial state) as an adaptation to the nutritional environment. While alterations in the expression level of the transcription factor SREBP-1c are known to be critical for nutritionally regulated lipogenesis, upstream mechanisms governing Srebf1 expression remain unclear. Here, we show that the fasting-induced transcription factor KLF15, a key regulator of gluconeogenesis, forms a complex with LXR/RXR, specifically on the Srebf1 promoter. This complex recruits the corepressor RIP140 instead of the coactivator SRC1, resulting in reduced Srebf1 and thus downstream lipogenic enzyme expression during the early and euglycemic period of fasting prior to hypoglycemia and PKA activation. Through this mechanism, KLF15 overexpression specifically ameliorates hypertriglyceridemia without affecting LXR-mediated cholesterol metabolism. These findings reveal a key molecular link between glucose and lipid metabolism and have therapeutic implications for the treatment of hyperlipidemia.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27545894 PMCID: PMC5031553 DOI: 10.1016/j.celrep.2016.07.069
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423